Search research articles
Contact Us
Filters
Showing results (321-330 of 401) with videos related to
Page
of 41
Sort By:
Molecules (Basel, Switzerland)
|
December 23, 2020
PARP Theranostic Auger Emitters Are Cytotoxic in BRCA Mutant Ovarian Cancer and Viable Tumors from Ovarian Cancer Patients Enable Ex-Vivo Screening of Tumor Response
Aladdin Riad, Sarah B Gitto, Hwan Lee, et al.
Medrxiv : the Preprint Server for Health Sciences
|
November 24, 2025
Mu-opioid receptor availability in patients with opioid use disorder treated with either methadone or buprenorphine
Jacob G Dubroff, Chia-Ju Hsieh, Hsiaoju Lee, et al.
Journal of Medicinal Chemistry
|
March 11, 2025
Structure-Activity Relationships and Evaluation of 2-(Heteroaryl-cycloalkyl)-1<i>H</i>-indoles as Tauopathy Positron Emission Tomography Radiotracers
Jeffrey S Stehouwer, Guofeng Huang, Dinahlee Saturnino Guarino, et al.
American Journal of Nuclear Medicine and Molecular Imaging
|
March 14, 2018
Open letter to journal editors on: international consensus radiochemistry nomenclature guidelines
Heinz H Coenen, Antony D Gee, Michael Adam, et al.
Nuclear Medicine Communications
|
February 14, 2018
Open letter to journal editors on: International Consensus Radiochemistry Nomenclature Guidelines
Heinz H Coenen, Antony D Gee, Michael Adam, et al.
Nuclear Medicine and Biology
|
May 26, 2019
Status of the 'consensus nomenclature rules in radiopharmaceutical sciences' initiative
Heinz H Coenen, Antony D Gee, Michael Adam, et al.
Synapse (New York, N.Y.)
|
April 1, 1997
Imaging of cholinergic terminals using the radiotracer [18F](+)-4-fluorobenzyltrozamicol: in vitro binding studies and positron emission tomography studies in nonhuman primates
R H Mach, M L Voytko, R L Ehrenkaufer, et al.
Bioorganic & Medicinal Chemistry Letters
|
August 8, 2019
Design, synthesis, and evaluation of N-(4-(4-phenyl piperazin-1-yl)butyl)-4-(thiophen-3-yl)benzamides as selective dopamine D<sub>3</sub> receptor ligands
Peng-Jen Chen, Michelle Taylor, Suzy A Griffin, et al.
Journal of Medicinal Chemistry
|
November 12, 1993
18F-labeled benzamides for studying the dopamine D2 receptor with positron emission tomography
R H Mach, R R Luedtke, C D Unsworth, et al.
Molecular Cancer
|
July 17, 2007
Selective sigma-2 ligands preferentially bind to pancreatic adenocarcinomas: applications in diagnostic imaging and therapy
Hiroyuki Kashiwagi, Jonathan E McDunn, Peter O Simon, et al.
Page
of 41
Search research articles
Search
Showing results (321-330 of 401) with videos related to
Sort By:
Page
of 41
Molecules (Basel, Switzerland)
|
December 23, 2020
PARP Theranostic Auger Emitters Are Cytotoxic in BRCA Mutant Ovarian Cancer and Viable Tumors from Ovarian Cancer Patients Enable Ex-Vivo Screening of Tumor Response
Aladdin Riad, Sarah B Gitto, Hwan Lee, et al.
Medrxiv : the Preprint Server for Health Sciences
|
November 24, 2025
Mu-opioid receptor availability in patients with opioid use disorder treated with either methadone or buprenorphine
Jacob G Dubroff, Chia-Ju Hsieh, Hsiaoju Lee, et al.
Journal of Medicinal Chemistry
|
March 11, 2025
Structure-Activity Relationships and Evaluation of 2-(Heteroaryl-cycloalkyl)-1<i>H</i>-indoles as Tauopathy Positron Emission Tomography Radiotracers
Jeffrey S Stehouwer, Guofeng Huang, Dinahlee Saturnino Guarino, et al.
American Journal of Nuclear Medicine and Molecular Imaging
|
March 14, 2018
Open letter to journal editors on: international consensus radiochemistry nomenclature guidelines
Heinz H Coenen, Antony D Gee, Michael Adam, et al.
Nuclear Medicine Communications
|
February 14, 2018
Open letter to journal editors on: International Consensus Radiochemistry Nomenclature Guidelines
Heinz H Coenen, Antony D Gee, Michael Adam, et al.
Nuclear Medicine and Biology
|
May 26, 2019
Status of the 'consensus nomenclature rules in radiopharmaceutical sciences' initiative
Heinz H Coenen, Antony D Gee, Michael Adam, et al.
Synapse (New York, N.Y.)
|
April 1, 1997
Imaging of cholinergic terminals using the radiotracer [18F](+)-4-fluorobenzyltrozamicol: in vitro binding studies and positron emission tomography studies in nonhuman primates
R H Mach, M L Voytko, R L Ehrenkaufer, et al.
Bioorganic & Medicinal Chemistry Letters
|
August 8, 2019
Design, synthesis, and evaluation of N-(4-(4-phenyl piperazin-1-yl)butyl)-4-(thiophen-3-yl)benzamides as selective dopamine D<sub>3</sub> receptor ligands
Peng-Jen Chen, Michelle Taylor, Suzy A Griffin, et al.
Journal of Medicinal Chemistry
|
November 12, 1993
18F-labeled benzamides for studying the dopamine D2 receptor with positron emission tomography
R H Mach, R R Luedtke, C D Unsworth, et al.
Molecular Cancer
|
July 17, 2007
Selective sigma-2 ligands preferentially bind to pancreatic adenocarcinomas: applications in diagnostic imaging and therapy
Hiroyuki Kashiwagi, Jonathan E McDunn, Peter O Simon, et al.
Page
of 41